NO20085028L - Substituerte karboksamider - Google Patents

Substituerte karboksamider

Info

Publication number
NO20085028L
NO20085028L NO20085028A NO20085028A NO20085028L NO 20085028 L NO20085028 L NO 20085028L NO 20085028 A NO20085028 A NO 20085028A NO 20085028 A NO20085028 A NO 20085028A NO 20085028 L NO20085028 L NO 20085028L
Authority
NO
Norway
Prior art keywords
substituted carboxamides
substituted
carboxamides
formula
pharmaceutically acceptable
Prior art date
Application number
NO20085028A
Other languages
English (en)
Other versions
NO341474B1 (no
Inventor
Kumiko Takeuchi
Matthew Joseph Fisher
Ryan Thomas Backer
Steven Lee Kuklish
Sean Patrick Hollinshead
Edward C R Smith
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20085028L publication Critical patent/NO20085028L/no
Publication of NO341474B1 publication Critical patent/NO341474B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende søknad angår en substituert karboksamidforbindelse med formel I, eller et farmasøytisk akseptabelt salt derav, som definert heri, en farmasøytisk sammensetning derav, og dens anvendelse ved behandling smerte.
NO20085028A 2006-06-08 2008-12-02 Substituerte karboksamider, farmasøytiske sammensetninger omfattende slike og anvendelse. NO341474B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08
PCT/US2007/070572 WO2008103185A2 (en) 2006-06-08 2007-06-07 Substituted carboxamides as group i metabotropic receptor antagonists

Publications (2)

Publication Number Publication Date
NO20085028L true NO20085028L (no) 2008-12-02
NO341474B1 NO341474B1 (no) 2017-11-27

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085028A NO341474B1 (no) 2006-06-08 2008-12-02 Substituerte karboksamider, farmasøytiske sammensetninger omfattende slike og anvendelse.

Country Status (30)

Country Link
US (1) US7960419B2 (no)
EP (1) EP2076502B1 (no)
JP (1) JP5108878B2 (no)
KR (1) KR101051559B1 (no)
CN (1) CN101466691B (no)
AT (1) ATE509921T1 (no)
AU (1) AU2007347428B2 (no)
BR (1) BRPI0712862A2 (no)
CA (1) CA2652074C (no)
CR (1) CR10410A (no)
CY (1) CY1111588T1 (no)
DK (1) DK2076502T3 (no)
EA (1) EA014233B1 (no)
EC (1) ECSP088939A (no)
ES (1) ES2362949T3 (no)
HR (1) HRP20110436T1 (no)
IL (1) IL195632A (no)
MA (1) MA30620B1 (no)
MX (1) MX2008015485A (no)
MY (1) MY148084A (no)
NO (1) NO341474B1 (no)
NZ (1) NZ573352A (no)
PL (1) PL2076502T3 (no)
PT (1) PT2076502E (no)
RS (1) RS51818B (no)
SI (1) SI2076502T1 (no)
TN (1) TNSN08506A1 (no)
UA (1) UA95480C2 (no)
WO (1) WO2008103185A2 (no)
ZA (1) ZA200809111B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
BRPI0910692A2 (pt) 2008-04-04 2018-03-27 Lilly Co Eli 3-indazolil-4-piridilisotiazóis
EP2443113A1 (en) * 2009-06-15 2012-04-25 The University Of Edinburgh Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
KR101702159B1 (ko) 2009-09-16 2017-02-02 더 유니버시티 오브 에든버러 （４―페닐―피페리딘―1―일）―［５―（1ｈ―피라졸―４―일）―티오펜―３―일］―메탄온 화합물 및 그의 용도
ES2543692T3 (es) 2010-04-29 2015-08-21 The University Of Edinburgh (8-aza-biciclo[3.2.1biciclo[oct-8-il)-[5-(1H-pirazol-4-il)-tiofeno-3-il]-metanonas 3,3-disustituidas como inhibidores de 11beta-HSD1
EP2921489B1 (en) 2012-11-13 2017-09-06 Nissan Chemical Industries, Ltd. 2-pyridone compound
EP3515919A1 (de) 2016-09-23 2019-07-31 Bayer Aktiengesellschaft N3-cyclisch substituierte thienouracile und ihre verwendung
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) * 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
BR0211742A (pt) * 2001-08-06 2004-08-24 Pharmacia Italia Spa Derivados de aminoisoxazole ativos como inibidores de cinase
WO2005030128A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Pyrazole modulators of metabotropic glutamate receptors
WO2005113534A2 (en) * 2004-05-12 2005-12-01 Schering Corporation Cxcr1 and cxcr2 chemokine antagonists
BRPI0515571A (pt) * 2004-09-23 2008-07-29 Pfizer Prod Inc agonistas de receptor de trombopoetina

Also Published As

Publication number Publication date
UA95480C2 (uk) 2011-08-10
SI2076502T1 (sl) 2011-09-30
BRPI0712862A2 (pt) 2012-12-18
CY1111588T1 (el) 2015-10-07
TNSN08506A1 (en) 2010-04-14
PL2076502T3 (pl) 2011-09-30
EA014233B1 (ru) 2010-10-29
CA2652074A1 (en) 2008-08-28
CN101466691B (zh) 2011-07-27
ES2362949T3 (es) 2011-07-15
DK2076502T3 (da) 2011-07-25
MY148084A (en) 2013-02-28
PT2076502E (pt) 2011-06-07
WO2008103185A2 (en) 2008-08-28
ECSP088939A (es) 2009-01-30
KR101051559B1 (ko) 2011-07-22
NZ573352A (en) 2011-10-28
CN101466691A (zh) 2009-06-24
RS51818B (sr) 2011-12-31
WO2008103185A3 (en) 2008-10-30
NO341474B1 (no) 2017-11-27
CA2652074C (en) 2013-08-06
JP2009539874A (ja) 2009-11-19
MA30620B1 (fr) 2009-08-03
MX2008015485A (es) 2009-03-06
IL195632A0 (en) 2009-09-01
EP2076502A2 (en) 2009-07-08
HRP20110436T1 (hr) 2011-08-31
AU2007347428A1 (en) 2008-08-28
CR10410A (es) 2008-11-28
EP2076502B1 (en) 2011-05-18
US20090182025A1 (en) 2009-07-16
KR20090008460A (ko) 2009-01-21
JP5108878B2 (ja) 2012-12-26
EA200870516A1 (ru) 2009-06-30
HK1131984A1 (en) 2010-02-12
ZA200809111B (en) 2009-12-30
ATE509921T1 (de) 2011-06-15
IL195632A (en) 2013-11-28
AU2007347428B2 (en) 2012-02-09
US7960419B2 (en) 2011-06-14

Similar Documents

Publication Publication Date Title
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
CY1111588T1 (el) Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
SI2205244T1 (sl) Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
EA201071043A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1
PT1973540E (pt) Utilização de derivados heterocíclicos benzo-fundidos de sulfamida para o tratamento de dor
MX2009005798A (es) Recuperacion de apoplejia.
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
ATE474574T1 (de) Imidazoazephinonverbindungen
MX2008008470A (es) Nuevos derivados pirrolicos con actividad inhibidora de desacetilasa de histonas.
EA200970368A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
EA200802000A1 (ru) Фармацевтически приемлемые соли и полиморфные формы
EA200870287A1 (ru) Амидные производные в качестве лигандов ионных каналов и фармацевтические композиции и способы их применения
JO2965B1 (en) The use of ferroxine in the treatment or prevention of malaria
DOP2008000064A (es) Carboxamidas sustituidas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees